Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/25225
Title: | Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding |
Author: | Carulla Martí, Patricia Bribián Arruego, Ana Rangel Rincones, Alejandra Helena Gavín Marín, Rosalina Ferrer, Isidro (Ferrer Abizanda) Caelles Franch, Carme Río Fernández, José Antonio del Llorens Torres, Franc |
Keywords: | Prions Malalties per prions Prions Prion diseases |
Issue Date: | 29-Jun-2011 |
Publisher: | American Society for Cell Biology |
Abstract: | Cellular prion protein (PrPC) is a glycosyl-phosphatidylinositol¿anchored glycoprotein. When mutated or misfolded, the pathogenic form (PrPSC) induces transmissible spongiform encephalopathies. In contrast, PrPC has a number of physiological functions in several neural processes. Several lines of evidence implicate PrPC in synaptic transmission and neuroprotection since its absence results in an increase in neuronal excitability and enhanced excitotoxicity in vitro and in vivo. Furthermore, PrPC has been implicated in the inhibition of N-methyl-D-aspartic acid (NMDA)¿mediated neurotransmission, and prion protein gene (Prnp) knockout mice show enhanced neuronal death in response to NMDA and kainate (KA). In this study, we demonstrate that neurotoxicity induced by KA in Prnp knockout mice depends on the c-Jun N-terminal kinase 3 (JNK3) pathway since Prnpo/oJnk3o/o mice were not affected by KA. Pharmacological blockage of JNK3 activity impaired PrPC-dependent neurotoxicity. Furthermore, our results indicate that JNK3 activation depends on the interaction of PrPC with postsynaptic density 95 protein (PSD-95) and glutamate receptor 6/7 (GluR6/7). Indeed, GluR6¿PSD-95 interaction after KA injections was favored by the absence of PrPC. Finally, neurotoxicity in Prnp knockout mice was reversed by an AMPA/KA inhibitor (6,7-dinitroquinoxaline-2,3-dione) and the GluR6 antagonist NS-102. We conclude that the protection afforded by PrPC against KA is due to its ability to modulate GluR6/7-mediated neurotransmission and hence JNK3 activation. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1091/mbc.E11-04-0321 |
It is part of: | Molecular Biology of the Cell, 2011, vol. 22, núm. 17, p. 3041-3054 |
URI: | https://hdl.handle.net/2445/25225 |
Related resource: | http://dx.doi.org/10.1091/mbc.E11-04-0321 |
ISSN: | 1059-1524 |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
602468.pdf | 1.84 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License